Atyr Pharma's general counsel Nancy Denyes sells $3,398 in stock
Nancy Denyes, General Counsel at aTyr Pharma Inc. (NASDAQ:ATYR), recently reported a sale of company shares. According to a Form 4 filing with the Securities and Exchange Commission, Denyes sold 899 ...
Neurocrine Biosciences CCO sells shares worth $184,598
Eric Benevich, the Chief Commercial Officer of Neurocrine Biosciences Inc (NASDAQ:NBIX), recently sold 1,207 shares of the company's common stock. The shares were sold at an average price of $152.94, ...